(lp0
S'GALE APRIL 14 ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors ... PR Newswire  - Apr 12, 2017 NEW YORK, April 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities  from August 11, 2014 through January 31, 2017, both dates inclusive (the &quot;Class&nbsp;...'
p1
aS"Galena Biopharma, Inc. in 3 Charts Fox Business - Nov 23, 2016 It's been a rocky road to travel for Galena Biopharma . After a decade of being in business and several corporate name changes along the way, where do things stand for the biotech right now -- and what might the future hold?"
p2
aS'GALE APRIL 14 ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors ... Yahoo Finance - Apr 12, 2017 NEW YORK, April 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities  from August 11, 2014 through January 31, 2017, both dates inclusive  of the&nbsp;...Hot Stock in Focus: Galena Biopharma, Inc.  - StandardOracleZacks Investment Research Upgrades Galena Biopharma Inc  to &quot;Strong-Buy&quot; - Sports Perspectives'
p3
aS"Galena Biopharma Inc  Announces Positive Interim Data from the Company's ... Smarter Analyst - Apr 4, 2017 Galena Biopharma Inc  announced a poster was presented on the Company's NeuVax  investigator-sponsored Phase 2 clinical trial  in high-risk, HER2 3+ patients at the American Association for Cancer Research&nbsp;...Galena Biopharma Inc.  Soars 6.6% on April 04 - Equities.comGalena Biopharma Presents Positive Interim Safety Data on the NeuVax ... - Yahoo Finance"
p4
aS'Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire  - Feb 13, 2017 SAN RAMON, Calif., Feb. 13, 2017  -- Galena Biopharma, Inc. , a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced the closing of its&nbsp;...'
p5
aS"Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim ... GlobeNewswire  - Feb 21, 2017 SAN RAMON, Calif., Feb. 21, 2017  -- Galena Biopharma, Inc. , a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company's&nbsp;..."
p6
aS'Lundin Law PC Announces Securities Class Action Lawsuit against Galena ... ValueWalk - Mar 29, 2017 LOS ANGELES, April 03, 2017  - Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Galena Biopharma, Inc.   concerning possible violations of federal&nbsp;...INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit ... - Virtual-Strategy Magazine'
p7
aS"DEADLINE TOMORROW: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Yahoo Finance - Apr 13, 2017 IRVINE, CA / ACCESSWIRE / April 13, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Galena Biopharma, Inc.  . Investors who purchased or otherwise acquired the Company's&nbsp;..."
p8
aS"4-DAY DEADLINE: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Yahoo Finance - Apr 10, 2017 IRVINE, CA / ACCESSWIRE / April 10, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Galena Biopharma, Inc.  . Investors, who purchased or otherwise acquired the Company's&nbsp;..."
p9
aS'Which insiders are selling Galena Biopharma, Inc. ? Post Analyst - 21 hours ago Galena Biopharma, Inc.  reached 7.57% versus a 1-year low price of $0.16. The stock was last seen 0.99% higher, reaching at $0.57 on Apr. 13, 2017.Galena Biopharma Inc  Short Interest Up 40.4% in March - The Cerbat GemGalena Biopharma  Receives Daily News Sentiment Rating of 0.17 - Sports Perspectives'
p10
a.